A study from Li et al. revealed that high level of insulin-like growth factor-1 (IGF1) was associated with advanced clinical stage and liver metastases of ovarian cancer patients by analyzing the expression of IGF1 in epithelial ovarian cancer clinical specimens. This evidence concerns the gene IGF1 and ovarian carcinoma.